|
|
|
Insider
Information: |
Crandell Keith |
Relationship: |
Director, 10% Owner |
City: |
Chicago |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
14 |
|
Direct
Shares |
14,726,492 |
|
Indirect Shares
|
20,997,912 |
|
|
Direct
Value |
$341,415,358 |
|
|
Indirect Value
|
$402,449,921 |
|
|
Total
Shares |
35,724,404 |
|
|
Total
Value |
$743,865,279 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-35.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Illumina Inc |
ILMN |
Former 10% Holder |
2004-02-03 |
6,423 |
2004-02-03 |
2,915,298 |
Premium* |
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2004-05-27 |
222,500 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
2004-03-19 |
0 |
2004-03-19 |
2,054,271 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
10% Owner |
2013-07-29 |
3,860,738 |
2013-07-29 |
0 |
Premium* |
|
Adesto Technologies Corp |
IOTS |
Director |
2019-06-04 |
25,396 |
2015-10-30 |
2,276,511 |
Premium* |
|
Xtera Communications, Inc. |
XCOM |
10% Owner |
|
0 |
2015-11-17 |
1,885,090 |
Premium* |
|
Phaserx, Inc. |
PZRX |
10% Owner |
2016-05-23 |
10,048 |
2016-05-23 |
2,854,222 |
Premium* |
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
10% Owner |
2017-08-01 |
0 |
2017-08-01 |
882,493 |
Premium* |
|
Quanterix Corp |
QTRX |
|
2023-01-03 |
130,066 |
2021-11-18 |
0 |
Premium* |
|
Twist Bioscience Corp |
TWST |
|
2024-02-06 |
18,004 |
2022-02-08 |
76,047 |
Premium* |
|
Denali Therapeutics Inc. |
DNLI |
10% Owner |
2019-08-08 |
10,668,749 |
2019-08-08 |
0 |
Premium* |
|
Karuna Therapeutics, Inc. |
KRTX |
10% Owner |
2021-04-13 |
918 |
2021-04-13 |
1,456,435 |
Premium* |
|
908 Devices Inc. |
MASS |
|
2023-06-14 |
6,150 |
2023-06-14 |
5,725,045 |
Premium* |
|
Da32 Life Science Tech Acquisiti... |
DALS |
Director, 10% Owner |
2021-07-30 |
0 |
2023-07-28 |
650,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
102 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QTRX |
Quanterix Corp |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,237 |
64,398 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
Director |
|
2021-05-19 |
4 |
A |
$0.00 |
$0 |
I/I |
11,463 |
119,635 |
0 |
- |
|
QTRX |
Quanterix Corp |
Director |
|
2021-03-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
13,643 |
28,069 |
0 |
- |
|
QTRX |
Quanterix Corp |
Director |
|
2021-03-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
13,644 |
41,713 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
Director |
|
2021-02-11 |
4 |
A |
$0.00 |
$0 |
I/I |
14,561 |
97,253 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
|
|
2020-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
22,580 |
82,692 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
|
|
2020-09-02 |
4 |
A |
$0.00 |
$0 |
I/I |
25,264 |
60,112 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
|
|
2020-08-18 |
4 |
A |
$0.00 |
$0 |
I/I |
34,848 |
34,848 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
Director |
|
2021-08-12 |
4 |
S |
$106.98 |
$4,664,392 |
I/I |
(43,588) |
76,047 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
Director |
|
2018-11-02 |
4 |
B |
$14.00 |
$1,050,000 |
I/I |
75,000 |
954,146 |
2.25 |
- |
|
TWST |
Twist Bioscience Corp |
|
|
2020-12-07 |
4 |
S |
$103.40 |
$7,755,000 |
I/I |
(75,000) |
288,104 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
10% Owner |
|
2020-11-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(150,000) |
1,606,435 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
10% Owner |
|
2021-01-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(150,000) |
1,531,435 |
0 |
- |
|
KRTX |
Karuna Therapeutics, Inc. |
10% Owner |
|
2021-04-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(150,000) |
1,456,435 |
0 |
- |
|
CYCC |
Cyclacel Pharmaceuticals ... |
10% Owner |
|
2004-03-19 |
4 |
B |
$8.00 |
$1,500,000 |
I/I |
187,500 |
2,054,271 |
1.5 |
- |
|
QTRX |
Quanterix Corp |
Director |
|
2017-12-11 |
4 |
B |
$15.00 |
$3,990,000 |
I/I |
266,000 |
1,537,684 |
2.25 |
- |
|
QTRX |
Quanterix Corp |
|
|
2021-11-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(290,250) |
0 |
0 |
- |
|
XCOM |
Xtera Communications, Inc... |
10% Owner |
|
2015-11-17 |
4 |
B |
$5.00 |
$1,500,000 |
I/I |
300,000 |
1,885,090 |
1.5 |
- |
|
MASS |
908 Devices Inc. |
Director |
|
2020-12-22 |
4 |
B |
$20.00 |
$6,000,000 |
I/I |
300,000 |
5,725,045 |
2.25 |
% |
|
TWST |
Twist Bioscience Corp |
Director |
|
2021-05-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(300,000) |
89,412 |
0 |
- |
|
ILMN |
Illumina Inc |
10% Owner |
|
2003-11-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(300,001) |
3,315,298 |
|
- |
|
QTRX |
Quanterix Corp |
|
|
2021-08-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(310,000) |
354,381 |
0 |
- |
|
QTRX |
Quanterix Corp |
|
|
2021-08-17 |
4 |
D |
$0.00 |
$0 |
I/I |
(310,000) |
233,692 |
0 |
- |
|
QTRX |
Quanterix Corp |
|
|
2021-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(310,000) |
113,003 |
0 |
- |
|
TWST |
Twist Bioscience Corp |
Director |
|
2021-05-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(314,938) |
0 |
0 |
- |
|
102 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|